Permanent Pacemaker Insertion Medication

1. Samii SM. Indications for pacemakers, implantable cardioverter-defibrillator and cardiac resynchronization devices. Med Clin North Am. 2015 Jul. 99 (4):795-804. [Medline].

2. Zhan C, Baine WB, Sedrakyan A, Steiner C. Cardiac device implantation in the United States from 1997 through 2004: a population-based analysis. J Gen Intern Med. 2008 Jan. 23 Suppl 1:13-9. [Medline].

3. Aquilina O. A brief history of cardiac pacing. Images Paediatr Cardiol. 2006 Apr. 8(2):17-81. [Medline].

4. [Guideline] Baddour LM, Epstein AE, Erickson CC, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010 Jan 26. 121(3):458-77. [Medline]. [Full Text].

5. [Guideline] Vardas PE, Auricchio A, Blanc JJ, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur Heart J. 2007 Sep. 28(18):2256-95. [Medline]. [Full Text].

6. [Guideline] Dalia T, Amr BS. Pacemaker indications. StatPearls [Internet]. Updated: August 31, 2020. [Full Text].

7. [Guideline] Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008 May 27. 51 (21):e1-62. [Medline]. [Full Text].

8. Batra AS, Balaji S. Post operative temporary epicardial pacing: When, how and why?. Ann Pediatr Cardiol. 2008 Jul. 1(2):120-5. [Medline]. [Full Text].

9. Patel AM, Verma D, Jiang SF, et al. Permanent pacemaker implantation early after cardiac surgery: a descriptive study of pacemaker utility after one year of follow-up. J Card Surg. 2016 Mar. 31(3):132-8. [Medline].

10. Debski M, Ulman M, Zabek A, Haberka K, Lelakowski J, Małecka B. Gender differences in dual-chamber pacemaker implantation indications and long-term outcomes. Acta Cardiol. 2016 Feb. 71(1):41-5. [Medline].

11. Pola-Gallego-de-Guzman MD, Ruiz-Bailen M, Martinez-Arcos MA, et al, for the ARIAM group. Implant of permanent pacemaker during acute coronary syndrome: Mortality and associated factors in the ARIAM registry. Eur Heart J Acute Cardiovasc Care. 2018 Apr. 7(3):224-9. [Medline]. [Full Text].

12. Bernstein AD, Daubert JC, Fletcher RD, et al. The revised NASPE/BPEG generic code for antibradycardia, adaptive-rate, and multisite pacing. North American Society of Pacing and Electrophysiology/British Pacing and Electrophysiology Group. Pacing Clin Electrophysiol. 2002 Feb. 25(2):260-4. [Medline].

13. de Oliveira JC, Martinelli M, Nishioka SA, et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial. Circ Arrhythm Electrophysiol. 2009 Feb. 2(1):29-34. [Medline]. [Full Text].

14. Da Costa A, Kirkorian G, Cucherat M, et al. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation. 1998 May 12. 97(18):1796-801. [Medline]. [Full Text].

15. Rajappan K. Permanent pacemaker implantation technique: part I: arrhythmias. Heart. 2009 Mar. 95(3):259-64. [Medline].

16. Rajappan K. Permanent pacemaker implantation technique: part II. Heart. 2009 Feb. 95(4):334-42. [Medline].

17. Armaganijan LV, Toff WD, Nielsen JC, et al. Are elderly patients at increased risk of complications following pacemaker implantation? A meta-analysis of randomized trials. Pacing Clin Electrophysiol. 2012 Feb. 35(2):131-4. [Medline].

18. Hayes DL, Friedman PA. Implantation-related complications. In: Hayes DL, Friedman PA, eds. Cardiac Pacing, Defibrillation and Resynchronization. A Clinical Approach. 2nd ed. West Sussex, United Kingdom: Wiley-Blackwell; 2008. ch 6.

19. Niazi GZK, Masood A, Ahmed N,et al. Permanent pacemaker implantation associated tricuspid regurgitation. Asian Cardiovasc Thorac Ann. 2020 Oct 28. 218492320971114. [Medline].

20. Yarlagadda C. Pacemaker malfunction. Medscape Drugs & Diseases from WebMD. Available at http://emedicine.medscape.com/article/156583-overview. Updated: September 19, 2016; Accessed: September 20, 2016.

21. Klug D, Balde M, Pavin D, et al, for the PEOPLE Study Group. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation. 2007 Sep 18. 116(12):1349-55. [Medline]. [Full Text].

22. Nery PB, Fernandes R, Nair GM, et al. Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences. J Cardiovasc Electrophysiol. 2010 Jul. 21(7):786-90. [Medline].

23. Margey R, McCann H, Blake G, et al. Contemporary management of and outcomes from cardiac device related infections. Europace. 2010 Jan. 12(1):64-70. [Medline]. [Full Text].

24. Lekkerkerker JC, van Nieuwkoop C, Trines SA, et al. Risk factors and time delay associated with cardiac device infections: Leiden device registry. Heart. 2009 May. 95(9):715-20. [Medline].

25. Cengiz M, Okutucu S, Ascioglu S, et al. Permanent pacemaker and implantable cardioverter defibrillator infections: seven years of diagnostic and therapeutic experience of a single center. Clin Cardiol. 2010 Jul. 33(7):406-11. [Medline]. [Full Text].

26. Sohail MR, Uslan DZ, Khan AH, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007 May 8. 49(18):1851-9. [Medline]. [Full Text].

27. Steffel J, Holzmeister J, Abraham WT. Recent advances in cardiac resynchronization therapy. Postgrad Med. 2011 Mar. 123(2):18-26. [Medline].

28. [Guideline] Tracy CM, Epstein AE, Darbar D, et al, for the American College of Cardiology Foundation, American Heart Association Task Force on Practice Guidelines, et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. [corrected]. Circulation. 2012 Oct 2. 126(14):1784-800. [Medline]. [Full Text].

29. Kosztin A, Boros AM, Geller L, Merkely B. Cardiac resynchronisation therapy: current benefits and pitfalls. Kardiol Pol. 2018. 76(10):1420-5. [Medline]. [Full Text].

30. Bob-Manuel T, Nanda A, Latham S, Pour-Ghaz I, Skelton WP 4th, Khouzam RN. Permanent pacemaker insertion in patients with conduction abnormalities post transcatheter aortic valve replacement: a review and proposed guidelines. Ann Transl Med. 2018 Jan. 6(1):11. [Medline]. [Full Text].

31. Kim WK, Mollmann H, Walther T, Hamm CW. Predictors of permanent pacemaker implantation after ACURATE neo transcatheter heart valve implantation. Pacing Clin Electrophysiol. 2021 Feb. 44(2):410-5. [Medline]. [Full Text].

32. Konta L, Chubb MH, Bostock J, Rogers J, Rosenthal E. Twenty-seven years experience with transvenous pacemaker implantation in children weighing Circ Arrhythm Electrophysiol</i>. 2016 Feb. 9(2):e003422. [Medline]. [Full Text].

Chakri Yarlagadda, MD, FACC, FSCAI, FASNC, CCDS Director of Cardiac Rehabilitation, St Elizabeth Youngstown Hospital; Radiation Safety Officer, Mercy Health Cardiology

Chakri Yarlagadda, MD, FACC, FSCAI, FASNC, CCDS is a member of the following medical societies: American College of Cardiology, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions

Disclosure: Nothing to disclose.

Richard A Lange, MD, MBA President, Texas Tech University Health Sciences Center, Dean, Paul L Foster School of Medicine

Richard A Lange, MD, MBA is a member of the following medical societies: Alpha Omega Alpha, American College of Cardiology, American Heart Association, Association of Subspecialty Professors

Disclosure: Nothing to disclose.

Acknowledgments

The author thanks Dr. Walter Paladino for his contribution of the cardiac resynchronization therapy material.

• Print this section
• Print the entire contents of
• Print the entire contents of article